app. quartet, NCH2); dC(75 MHz, CDCl3) 167.1, 153.3, 152.7,
141.4, 137.1, 134.8, 128.5, 127.9, 127.4, 122.1, 115.9, 115.4, 82.9,
70.6, 69.7, 69.7 (sic), 67.2, 66.7, 39.8. (1 ArC peak missing); m/z
(ES) 823.2436 ([M + Na]+, C48H44FeN2NaO6 requires 823.2442),
823 (7%, [M + Na]+), 859 (100, [M + CH3CN + Na]+).
ArH2 & ArH4 & ArH6), 7.61 (4H, d, 3J = 8.8 Hz, stopper ArH),
7.08–7.29 (32H, m, stopper ArH & isophthalamide NH), 6.48
(4H, t, 3J = 8.9 Hz, hydroquinone ArH), 6.37 (4H, t, 3J = 8.9 Hz,
hydroquinone ArH), 5.98 (2H br s, CH CH), 4.73 (2H, s, Fc
CpH), 4.37 (2H, s, Fc CpH), 4.31 (3H, s, N+CH3) 4.04–4.06 (9H,
3
m, Fc Cp’H & CH2) 3.93 (4H, t, J = 4.4 Hz, CH2), 3.86 (4H,
N1, N3-Bis(2-(4-hydroxyphenoxy)ethyl)-5-ferrocenylisophthal-
amide (9). To a solution of 8 (400 mg, 0.50 mmol) dissolved
in CHCl3–CH3OH (1 : 1, 20 mL) was added 10% Pd/C (10% by
wt, 40 mg), and the reaction was stirred under an atmosphere of
m, CH2), 3.81 (4H, m, CH2) 3.70–3.72 (4H, m, CH2), 1.31 (s,
36H, (CH3)3); dC(125.8 MHz, CDCl3) 167.0, 158.3, 152.8, 152.0,
148.6, 146.8, 145.3, 144.0, 143.4, 141.8, 141.3, 134.3, 134.3 (sic),
134.1, 132.0, 131.0, 130.6, 130.4, 128.5, 127.4, 125.9, 124.4, 121.6,
120.1, 115.5, 114.7, 83.2, 70.8, 69.7, 69.5, 69.3, 67.7, 66.9, 66.8,
63.9, 49.6, 39.7, 34.3, 31.4; dF(282.4 MHz, CDCl3) -69.9 (d, 1J =
714 Hz, PF6); dP(121.5 MHz, CDCl3) -143.9 (septet, 1J = 714 Hz,
R
H2 for 16 h. The reaction mixture was filtered through Celiteꢀ,
the solvent removed in vacuo, to leave the product as a foaming
orange solid (310 mg, quant.). Mp > 148 ◦C (dec.); dH(300 MHz,
d6-DMSO) 8.94 (2H, s, OH), 8.87 (2H, t, 3J = 5.6 Hz, NH), 8.20
(1H, t, 4J = 1.5 Hz, isophthalamide ArH2), 8.13 (2H, d, 4J = 1.5 Hz,
isophthalamide ArH4 & H6), 6.65–6.82 (8H, m, hydroquinone
ArH), 4.93 (2H, t, 3J = 1.9 Hz, Fc CpH), 4.43 (2H, t, 3J = 1.9 Hz,
Fc CpH), 4.02–4.07 (9H, m, Fc Cp’H & OCH2), 3.60–3.66 (4H,
app. quartet, NCH2); dC(75 MHz, d6-DMSO) 166.0, 151.4, 151.2,
139.9, 134.6, 126.7, 124.1, 115.8, 115.5, 83.4, 69.5, 69.4, 66.6, 66.6
(sic) (1 peak missing CNH - coincidental with solvent); m/z (ES)
643.1504 ([M + Na]+, C34H32FeN2NaO6 requires 643.1502), 643
(5%, [M + Na]+), 679 (100, [M + CH3CN + NH4]+). In addition,
619 (100%, [M - H]-), 655 (43, [M + Cl]-) observed in negative
polarity mass spectrum.
PF6 ); m/z (ES) 1800.8605 ([M - PF6]+, C116H122FeN5O10 requires
-
1800.8541), 1801 (100%, [M - PF6]+).
Acknowledgements
We wish to thank the EPSRC for a DTA studentship (N. H. E.),
Johnson-Matthey for the loan of palladium catalysts, and Dr J. J.
Davis (University of Oxford) for use of electrochemical equipment.
Notes and References
1 For general reviews on rotaxanes and catenanes see: (a) T. Takata, N.
Kihara and Y. Furusho, Adv. Poly. Sci., 2004, 171, 1; (b) J.-P. Collin,
V. Hertz and J.-P. Sauvage, Top. Curr. Chem., 2005, 262, 29; (c) F. H.
Huang and H. W. Gibson, Prog. Polym. Sci., 2005, 30, 982; (d) G.
Wenz, B.-H. Han and A. Mu¨ller, Chem. Rev., 2006, 106, 782; (e) M.
D. Lankshear and P. D. Beer, Acc. Chem. Res., 2007, 40, 657; (f) K.
E. Griffiths and J. F. Stoddart, Pure Appl. Chem., 2008, 80, 485; (g) A.
Harada, A. Hashidzume, H. Yamaguchi and Y. Takashima, Chem.
Rev., 2009, 109, 5974; (h) J. J. Gassensmith, J. M. Baumes and B. D.
Smith, Chem. Commun., 2009, 6329; (i) J. D. Crowley, S. M. Goldup,
A.-L. Lee, D. A. Leigh and R. T. McBurney, Chem. Soc. Rev., 2009,
38, 1530; (j) Z. Niu and H. W. Gibson, Chem. Rev., 2009, 109, 6024;
(k) For a comprehensive review on the nanotechnological application
of interlocked molecules see: E. R. Kay, D. A. Leigh and F. Zerbetto,
Angew. Chem., Int. Ed., 2007, 46, 72.
Chloride salt of rotaxane (1+Cl-). Macrocycle precursor 5
(81 mg, 0.10 mmol) and 10+Cl- (110 mg, 0.10 mmol) were added
to dry CH2Cl2 and stirred for 30 min under a nitrogen atmosphere.
Grubbs 2nd generation catalyst (8.1 mg) was added, stirred under
a constant flow of nitrogen for 16 h. The reaction solvent was
removed in vacuo, and after purification by two prep silica gel
TLC plates (CH2Cl2–CH3OH 96 : 4, then EtOAc), rotaxane 1+Cl-
was isolated as an orange solid (48 mg, 25%). Mp > 230 ◦C
(dec.); dH(300 MHz, CDCl3): 10.30 (2H, s, py NH), 9.68 (1H,
s, pyridinium ArH4), 9.25 (2H, s, pyridinium ArH2 & ArH6), 8.77
(1H, s, isophthalamide ArH2), 8.55 (2H, s, isophthalamide NH),
2 M. J. Chmielewski, J. J. Davis and P. D. Beer, Org. Biomol. Chem., 2009,
7, 415.
3
8.26 (2H, s, isophthalamide ArH4 & ArH6), 7.84 (4H, d, J =
3 Examples of cation-binding rotaxanes: (a) K. Hiratani, M. Kaneyama,
Y. Nagawa, E. Koyama and M. Kanesato, J. Am. Chem. Soc., 2004,
126, 13568; (b) N. C. Chen, P. Y. Huang, C. C. Lau, Y. H. Liu, Y. Wang,
S. M. Peng and S. H. Chiu, Chem. Commun., 2007, 4122; (c) S. S. Zhu,
P. J. Carroll and T. M. Swager, J. Am. Chem. Soc., 1996, 118, 8713;
(d) S. S. Zhu and T. M. Swager, J. Am. Chem. Soc., 1997, 119, 12568.
4 Examples of anion-binding rotaxanes: (a) J. A. Wisner, P. D. Beer, M.
G. B. Drew and M. R. Sambrook, J. Am. Chem. Soc., 2002, 124, 12469;
(b) D. Curiel and P. D. Beer, Chem. Commun., 2005, 1909; (c) M. R.
Sambrook, P. D. Beer, M. D. Lankshear, R. F. Ludlow and J. A. Wisner,
Org. Biomol. Chem., 2006, 4, 1529; (d) S. R. Bayly, T. M. Gray, M. J.
Chmielewski, J. J. Davis and P. D. Beer, Chem. Commun., 2007, 2234;
(e) L. M. Hancock and P. D. Beer, Chem.–Eur. J., 2009, 15, 42; (f) L.
Y. Zhao, J. J. Davis, K. M. Mullen, M. J. Chmielewski, R. M. J. Jacobs,
A. Brown and P. D. Beer, Langmuir, 2009, 25, 2935; (g) A. Brown, K.
M. Mullen, J. Ryu, M. J. Chmielweski, S. M. Santos, V. Felix, A. L.
Thompson, J. E. Warren, S. I. Pascu and P. D. Beer, J. Am. Chem. Soc.,
2009, 131, 4937; (h) K. M. Mullen, J. Mercurio, C. J. Serpell and P. D.
Beer, Angew. Chem., Int. Ed., 2009, 48, 4781; (i) A. J. McConnell, C. J.
Serpell, A. L. Thompson, D. R. Allan and P. D. Beer, Chem.–Eur. J.,
2010, 16, 1256; (j) J. J. Gassensmith, S. Matthys, J. J. Lee, A. Wojcik, P.
V. Kamat and B. D. Smith, Chem.–Eur. J., 2010, 16, 2916.
8.8 Hz, stopper NHArH), 7.06–7.26 (30H, m, stopper ArH), 6.45
(4H, d, 3J = 8.9 Hz, hydroquinone ArH), 6.20 (4H, d, 3J = 8.9 Hz,
hydroquinone ArH), 5.96 (2H, br s, CH CH), 4.68 (2H, app s, Fc
CpH), 4.32 (5H, app s, Fc CpH & N+CH3), 4.19 (4H, br s, CH2),
4.05 (app s, 4H, CH2), 4.00 (5H, s, Fc Cp’H), 3.75–3.85 (12H, m,
3 ¥ CH2), 1.32 (36H, s, (CH3)3); dC(125.8 MHz, CDCl3) 168.9,
158.1, 153.4, 151.9, 148.4, 146.9, 145.2, 144.8, 143.5, 140.4, 139.4,
134.8, 134.0, 133.4, 131.8, 131.1, 130.6, 129.9, 129.0, 127.4, 125.8,
124.3, 122.1, 120.4, 114.8, 114.5, 71.0, 69.3, 68.0, 66.1, 63.8, 48.8,
40.6, 34.3, 31.4 (in addition evidence of broad peaks attributed to
the four CpC); m/z (ES) 1800.8585 ([M - Cl]+, C116H122FeN5O10
requires 1800.8541), 1801 (100%, [M - Cl]+).
-
Hexafluorophosphate salt of rotaxane (1+PF6 ). Rotaxane
1+Cl- (72 mg, 0.039 mmol) was dissolved in CHCl3 (15 mL), and
then vigorously shaken with 0.1 M NH4PF6 (10 ¥ 10 mL), then
washed with H2O (3 ¥ 10 mL). The organic layer was separated,
then dried over MgSO4, with the solvent subsequently removed
in vacuo to yield rotaxane 1+PF6- as a yellow-orange solid (59 mg,
78%). Mp > 220 ◦C (dec.); dH(300 MHz, CDCl3) 9.23 (2H, s,
pyridinium NH), 8.90 (1H, s, pyridinium ArH4), 8.54 (2H, s,
pyridinium ArH2 & ArH6), 8.19–8.21 (3H, m, isophthalamide
5 J. L. Sessler, P. A. Gale and W.-S. Cho, Anion Receptor Chemistry, RSC,
Cambridge, 2006.
6 Illustrative examples of ferrocene-containing anion receptors: (a) P.
D. Beer, Z. Chen, A. J. Goulden, A. Graydon, S. E. Stokes and T.
Wear, J. Chem. Soc., Chem. Commun., 1993, 1834; (b) P. D. Beer, A.
R. Graydon, A. O. M. Johnson and D. K. Smith, Inorg. Chem., 1997,
This journal is
The Royal Society of Chemistry 2011
Org. Biomol. Chem., 2011, 9, 92–100 | 99
©